Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Smurfit WestRock plc Ordinary Shares (SW) Price & Performance

Inovio Pharmaceuticals IncTrade
Smurfit WestRock plc Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Smurfit WestRock plc Ordinary Shares — how do they compare? Inovio Pharmaceuticals Inc trades at $1.1 (market cap $112.19M), while Smurfit WestRock plc Ordinary Shares trades at $41.51 (market cap $21.74B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 193.8× Inovio Pharmaceuticals Inc's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.36% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and Smurfit WestRock plc Ordinary Shares for 0 Days on average.

INOSW
Market Cap
$112.19M$21.74B
Volume
3,201,2785,178,763
Sector
HealthConsumer Cyclical
52-Week High
$2.65$51.84
52-Week Low
$0.66$32.79
Typical Hold Time
43 Days0 Days
Enterprise Value
$83.51M$35.23B
Dividend Yield
—4.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals (INO) trades at $1.155, up 2.21% today, while showing bearish technical signals with negative cash flow and substantial losses. The company's financials reveal minimal revenue of $65,340 against an $84.95 million net loss in 2025, with profitability metrics deeply negative. However, analyst sentiment is optimistic with a 58.83% buy rating and $2.75 consensus price target, driven by the upcoming FDA decision on INO-3107 for recurrent respiratory papillomatosis by October 30, 2026.

INO presents high-risk speculation with potential for significant upside if FDA approval is secured, but carries substantial fundamental weaknesses including persistent cash burn and negative margins. Investors should weigh the binary outcome of the regulatory decision against the company's challenging financial position and technical bearishness.

Smurfit WestRock plc Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INO
95% Buy5% Sell
Avg holding period · 43 Days
SW
100% Buy0% Sell
Avg holding period · 0 Days

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO →

About Smurfit WestRock plc Ordinary Shares

Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.

Read more on SW →